What is PAGE?

1. The Community

PAGE represents a community with a shared interest in data analysis using the population approach. It is a non-profit organisation (company limited by guarantee) with registered office in England and Wales. If you want to be a part of this community then please register by clicking on my profile on your left. If you have entered your personal information before at this web-site but no longer know your password, it can be mailed to you automatically using the my profile link. If you've both changed your e-mail address and do not know your password, please contact Rik Schoemaker (rs@page-meeting.org); do not create a new profile!

2. The Meeting

Each year a meeting is held in June at a different European location. The upcoming meeting will be held in Venice, Italy, from 5 to 8 June 2012. Registration is now open but we have reached the maximum number of participants. You can still register but will be placed on a waiting list and will be notified as soon as a place becomes available.

3. The Online Journal

This web-site is also home of the official online journal PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe. ISSN 1871-6032. All the abstracts for the past PAGE meetings can be accessed online through either the search function on the left or by going to the relevant PAGE meeting. Each abstract is formally and uniformly referenced as indicated when viewing the abstract.

4. The Mobile platform

Abstract-viewer Apps for the upcoming meeting are available for free download in an iPhone and an Android version. Additionally, a mobile version of the PAGE web-site is available at m.page-meeting.org.

5. The PAGE pictures

Pictures of previous PAGE meetings can be found in our Picasa Web Album.
  

Links to other Population Approach Resources

NONMEM®

NONMEM® software from ICON Development Solutions

• NONMEM Software and Support
• NONMEM Users Net Archive
• NONMEM ftp Repository at ICON/GloboMax
• NONMEM Project Group, UCSF
• Introduction to NONMEM® in French 

Phoenix NLME™

is Pharsight's powerful new data processing and modeling software for population PK/PD analysis. Phoenix NLME 1.0 includes flexible tools to create models from an extensive built-in library of models, graphically, or via user-supplied code. Features include graphical workflows that integrate data preparation, model selection and generation of tables and figures, and parallelized model estimation engines designed to take advantage of significant speed gains available on modern computers running multiple processors. Phoenix NLME 1.0 can be optionally configured to connect with a drug development organization's computer grids and clusters.

PKUK

is a non-profit organisation with annual meetings providing an open forum for discussing all PKPD issues in drug development as well as clinical implications of PKPD studies.

UPSS

is the Uppsala Pharmacometric Summer School intended for PhD students from all around the world. The next edition will be held 6-17 August 2012 and the topics are PKPD modeling of continuous and categorical data in NONMEM7 and covariate model building. The program includes lectures and hands-on sessions, student group work and presentations. Instructors are Prof. Mats Karlsson and colleagues from the Uppsala Pharmacometric Research Group.

A web animation

developed by Inria about the Population Approach is now available online. The objective of this animation is to explain that this approach is relevant in many fields (biology, agronomy, toxicology, pharmacology,…) and to show an application in PK modelling in a little more detail.

PODE 2011

the Workshop on "Optimum Design for Mixed Effects Non-Linear and Generalized Linear Models" took place in August, 9-12, 2011, at the Isaac Newton Institute for Mathematical Sciences, Cambridge, UK. One of the days of the Workshop was devoted to population PK/PD optimum design, as a continuation of the PODE meetings. 

Xpose 4

is a model building aid for population analysis using NONMEM®. Xpose produces various plots and analyses to facilitate data set checkout, goodness-of-fit analysis, model exploration and visualization, model diagnostics, candidate covariate identification and model comparison.  Xpose 4 is written in the programming language R and allows for integration into nearly any model building platform. New functionality in Xpose 4 allows the user to create simulation based reference diagnostics, compute the conditional weighted residuals and modify standard Xpose graphics to create publication quality figures.

Perl-speaks-NONMEM (PsN)

is a collection of Perl modules and programs aiding in the development of non-linear mixed effect models using NONMEM®. The functionality ranges from simpler tasks such as parameter estimate extraction from output files, data file sub setting and resampling, to advanced computer-intensive statistical methods. PsN includes both stand-alone tools as well as development libraries for method developers.

Metrum Institute Open-Source Tools

Metrum Institute, a non-profit organization, develops open-source modeling and simulation software tools as a service to the M&S community. See this link for more information and to download tools such as, NMQual, MIfuns, bugsParallel, bugsPKPDmodelLibrary and SASxport. Metrum Institute also participates in training, education and applied academic M&S research efforts.

Wings for NONMEM

WFN is a set of DOS batch command files and awk scripts to help NONMEM® users be more productive. The first version of WFN (Wheels for NONMEM) was written in 1989 at UC San Francisco. The unix csh and awk scripts evolved and were eventually ported to DOS in order to support NONMEM as part of the RIDO (Right Dose First Time) project.

Census

is a comprehensive Windows-based analysis project manager for NONMEM, providing detailed summary, comparison and overview of the runs comprising a given project, including the display of output data, simple post-run processing, numerical output diagnostics, fast diagnostic plots (through tight integration with R and Xpose) and run output management, complementary to other available modeling aids.

Piraña

is a free open-source graphical user interface for NONMEM and PsN, and provides a complete modeling environment, including model management, editing, running and evaluation of models. It is designed to streamline the modeling workflow, and to integrate seamlessly with other open-source software such as R, Xpose, and PsN, e.g. for the creation of diagnostic plots. Piraña can be used for modeling on your local PC, but can also be used as an interface to computer clusters. Piraña runs on Windows, Linux and Mac OS X. 

BUGS

is a general-purpose program for Bayesian statistical analysis. BUGS version 0.6 can handle a wide range of models including linear mixed-effect models. The 1.4 version of WinBUGS is currently available and is capable of fitting non-linear mixed effect models; a specialist Windows interface for PK modelling (PKBUGS) is included.

MONOLIX

is a program that implements the SAEM algorithm for estimation in nonlinear mixed-effects models with several nice new features: library of usual PK and PD models as well as discrete data models, additional graphical output, enhanced interface, handling of measurements below limit of quantification, MLXTRAN language for easy model description, etc. Available as a MATLAB program or as a stand-alone executable version that does not require MATLAB.

PFIM

is a collection of R functions for population designs evaluation and optimisation. It is based on the expression of the Fisher information matrix in nonlinear mixed effects models. The recent versions are PFIM Interface 2.1, for single response models which includes a graphical user interface, and PFIM 3.0 for multiple response models. Several new features are proposed. A library of usual PK models is available and other models can be written using an analytical form or using a differential equations system. Regarding optimisation, it can be performed using either the Simplex algorithm or the Fedorov-Wynn algorithm.

WinPOPT

is standalone software for the optimal design of population PK and PKPD studies. The software runs on a Windows platform either as standalone or over a network. WinPOPT contains a library of PK models and offers flexibility in the input of user-defined models. Design and technical support are available.

PopDesign

is an e-mail list server for questions and comments about the design of population PK and PKPD studies. The PopDesign mailing list would be an appropriate place to ask questions and post comments about the design of any study for which nonlinear mixed effects modelling is the proposed analysis tool. Members of the list includes those who have developed nonlinear mixed effects models design software: PFIM, PFIM_OPT, PkStamp, PopDes, PopED, POPT, WinPOPT.

PK-Sim®

is a unique software tool for whole-body physiologically-based pharmacokinetic (PBPK) modeling and simulation. In particular it allows the straight forward construction of highly specific PK models that may be used to summarize the existing data and to extract the most information out of the experimental results generated thus far. 

EMEA

The European Agency for the Evaluation of Medicinal Products.

ICON Development Solutions (formerly GloboMax) 

specializes in the strategy and delivery of early drug development, with multi-disciplinary expertise from compound selection through to proof-of-concept clinical development.  Noted expertise is in non-clinical development, early phase clinical research, bioanalytical, PK, PD, modeling and simulation and regulatory affairs.  In addition to providing exclusive licensing and technical support for NONMEM®, ICON has introduced a NONMEM® shell called PDx-POP.

Exprimo NV

is a European consulting company with the emphasis of its activities focussed towards the application of quantitative, model based approaches at all stages of pharmaceutical development. Services offered include pharmacokinetic analysis and reporting, population PK/PD modelling as well as advanced drug-disease modelling and clinical trial simulations. All work is conducted to appropriate GCP or regulatory requirements.

Cognigen Corporation

is the industry leader in pharmacometric analysis. Close collaboration with our clients and a systematic approach to model-based drug development are the foundations of our success. Cognigen’s reputation for excellence stems from our highly experienced interdisciplinary teams, which combine reliability, integrity, and scientific acumen to deliver superior service.

EMF Consulting

is a group of pharmaceutical consultants who provide a wide range of drug development services. We offer consulting as members of a development team, we offer our expertise in the design, conduct, analysis and reporting of studies, we provide data sciences logistics, and write regulatory documents and PKPD modelling training.

LAP&P Consultants

provides interdisciplinary support on advanced pharmacokinetic and pharmacodynamic analyses to solve complex problems in preclinical and clinical drug development. LAP&P has a professional infrastructure for advanced PK/PD analyses and reporting for the pharmaceutical industry, based on the most recent developments in academic science. Services include Mixed Effect (population) analysis, Physiologically Based Pharmacokinetic (PB-PK) Modelling, disease progression analysis and clinical trial simulations.

Mango Solutions Ltd

is a UK based data analysis company.  Operating globally, we assist our customers in a number of different markets by delivering high performance data analysis solutions. Mango Solutions can help you to embed the power of sometimes complex statistical analysis directly into the decision making process; turning data into powerful information to support business decisions and putting powerful analysis tools into the hands of end users. Working professionally and effectively, we are happy to engage in a variety of work- from data analysis training to application development - meeting your specific needs. 

Pharmacokinetic Resources

maintained by David Bourne, OUHSC College of Pharmacy. The purpose of this page is to provide links to information about the discipline of Pharmacokinetics.

RFPK

is the Resource Facility for Population Kinetics, a research resource sponsored by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) within the US National Institutes of Health. RFPK's mission is to continuously improve the quality of research in the biomedical community by widely distributing software and expertise related to population analysis. RFPK encourages collaboration at all levels of biomedical research. Areas of emphasis include intermediary metabolism, lipid metabolism and pharmacokinetics and pharmacodynamics, among others.

The Laboratory of Applied Pharmacokinetics, USC

directed by Roger W. Jelliffe.

Metrum Research Group LLC

provides contract services aimed at enhancing biomedical R&D through quantitative modeling and simulation. Our collaborations with pharma/biotech industries are characterized by cutting-edge science, transfer of knowledge, quality deliverables and innovative, strategic application of M&S technologies. MetrumRG employs a full-time scientific staff with extensive experience in quantitative M&S. Our work is performed in and managed under quality assurance systems and our secured, managed computing infrastructure provides continuous and robust support for critical client projects.

Accelrys

develops and commercialises scientific business intelligence software and solutions that help accelerate science for clients in the Life Sciences, Energy, Chemicals, Aerospace, and Consumer Packaged Goods industries. Our solutions are used by biologists, chemists, materials scientists, IT and business professionals to aggregate, analyse, simulate, and visualise scientific data.  Our scientifically aware platform and predictive science tools help clients conduct experiments in-silico, make informed decisions, and reduce times for product development.

Arlenda

is a consulting company specialized in Applied “Modeling and Statistics” for translational sciences and Model-based Drug Development. With experts in pharmacokinetics and (Bayesian) statistics, it allows to make optimal use of PK-PD models to design and analyse clinical trials in early phases. Arlenda offers an integrated suite of services including statistical and PK analyses and reporting, TFLs production, SAP, DAP and PIP writing,  clinical trials predictions, adaptive design set up and conduct in accordance with GCP requirements.

DruDevO

With 20+ years of experience in modeling and simulation we specialize in consultancy for DRUg DEVelopment Optimization using M&S methods. Based on the experience in this field we have also developed a time saving NONMEM interface which also links Windows to Linux/Mosix systems. We comply with GCP and 21 CRF 11 guidelines.

Next Level Solutions

is a consulting company focusing on rapid turnaround population pk/pd analysis. We apply proprietary methods and high performance computing to standard population pk/pd software resulting in more robust solutions on a shorter timeline.

QuantPharm LLC

is a consulting company located in Maryland, US. It specializes in development and application of advanced mathematical modeling, simulation, and data mining methods to support pharmaceutical and biotechnology industries. QuantPharmTM offers fast, efficient and high quality population analysis of pharmacokinetic and pharmacodynamic data and model-based clinical trial simulations to support all stages of drug development, from pre-clinical to Phase IV.

Cellular Statistics, LLC

Tools and services in algebraic statistics and logic for  pharmacometrics applications.

Probayes

provide ProBT© which is a powerful modeling, inference, and learning platform inheriting 10 years of experience in the domain of Bayesian probabilistic computing, and ProBT-XL which makes Bayesian models prototyping and testing easier and quicker. It provides a Microsoft Excel graphical user interface to ProBT. Use it to design Bayesian networks while taking advantage of the worksheet environment and the Bayesian programming approach.

PRI

provides a wide range of Study Design (D-optimization), Pharmacokinetic, Pharmacodynamic, and Pharmacometric services performed by internationally recognized experts with experience working within industry, academia, and FDA. The PRI team analyzes clinical trial data and provides clear concise reports allowing faster, better informed decision-making during the drug development process and ensuring fewer queries during the regulatory review process.

Thermo Electron Corporation

is an ideal choice for companies seeking to standardize on LIMS, CDS and PK-PD solutions - supporting enterprise deployment and 21 CFR Part 11 compliance: Kinetica for population and standard PK/PD analysis; EP Series, an enterprise PK/PD data management solution, integrating with NONMEM, SAS, WinNonLin; SampleManager LIMS, an enterprise solution for multiple industries; Watson LIMS for pre-clinical & clinical bioanalysis; Galileo LIMS, for in vitro ADME studies; Nautilus LIMS, for discovery and R&D; Atlas CDS, for chromatographic instrument control, data acquisition and processing.

ASTER.CEPHAC

is a leading European contract research organization (CRO) providing clinical and bioanalytical services to pharmaceutical companies. With an average of more than 10 years experience and 3 full trained people dedicated to PK/PD, ASTER.CEPHAC provides the following services: PK and PK/PD analysis, population PK/PD modelling and simulation approaches, preparation of scientific publications and investigator's brochures.

qPharmetra

provides efficient, effective, and decision-focused pharmacometric consulting services to Pharma and Biotechnology organizations. Our experienced, senior modeling team performs a comprehensive range of analyses in support of all phases of drug development, including population PK, PK/PD, clinical trial simulation, clinical utility analysis and reporting. Further, we have standardized and automated our work processes from initial project preparation through final project documentation. The result: efficiently generated reports and presentations providing clear guidance to internal and external stakeholders in the drug development process.

Ann Arbor Pharmacometrics Group (A2PG)

is a functional service provider specializing in model-based drug development consulting for the pharmaceutical industry. Our consulting services include population pharmacokinetic and pharmacodynamic (pop PK/PD) modeling, and model-based clinical trial simulations to support trial designs, program strategy and decision-making. 

Shafi Consultancy Ltd

is a SAS programming group specialising in producing NONMEM ready files using raw data from clinical trial databases. We have 10 years of experience in producing datasets both for PK/PD analysis and for analysis using NONMEM. Using our extensive expertise, client specific standard process are established to handle missing and dirty data, to merge different types of covariates and to produce traceability and summary tables. This ensures datasets can be produced quickly and consistently in a timely manner for analysis.

Model Answers

is a well established pharmacometric consulting company that provides services to a global client network. The team delivers a range of highly innovative solutions with an emphasis on quality, transparency and reproducibility. With live project mapping, interim results management, sophisticated operating procedures and reporting systems, clients can trust Model Answers to deliver a superior product on time.

BAST Inc Limited

is a consulting business that was founded in 1991 with the purpose to provide population PK analysis to the pharmaceutical industry. We have widened our services considerably since 2010. Now we offer, in addition to standard popPKPD services, risk and utility assessments through mechanistic modelling. Our quantitative decision support adds value to projects of biotech companies in search of additional venture capital. 

Quantitative Solutions

is a global pharmacometrics consulting company with offices on both coasts of US as well as in Europe. We develop quantitative models of clinical PK, efficacy and safety data to enable better drug development decisions, including: dose selection, trial design, in-licensing drug evaluation, and more. Our expertise includes model-based meta-analysis, population PKPD modeling, and translational modeling. Our scientists are experts in integrating vast amount of data from diverse sources and developing realistic models to address key drug development questions. Our extensive drug development experience helps distinguish us in providing top quality M&S support to development teams.

Kinesis Pharma

aims to facilitate a fast and high quality development and registration process for medicinal products through consultancy and contract research services. Kinesis’ PK/PD modeling services include: exploratory analysis for instant decision-making (e.g. dose selection and trial design), meta-analysis and model-based extrapolations. Model based extrapolations include animal to human or adult to paediatric extrapolations for dose selection and answering “What if” questions. At Kinesis-Pharma the model is not a goal in itself, but a tool to provide the answers you seek.

Please send comments to Rik Schoemaker (rs@page-meeting.org)